Abstract Research using animal models has contributed significantly to realizing the goal of understanding dysfunction and improving the care of patients who suffer from dysphagia. But why should other researchers and the clinicians who see patients day in and day out care about this work? Results from studies of animal models have the potential to change and grow how we think about dysphagia research and practice in general, well beyond applying specific results to human studies. Animal research provides two key contributions to our understanding of dysphagia. The first is a more complete characterization of the physiology of both normal and pathological swallow than is possible in human subjects. The second is suggesting of specific, physiological, targets for development and testing of treatment interventions to improve dysphagia outcomes.
A Model for Dysphagia Research
The main goal of dysphagia research is to provide better care, if not cure our patients suffering from one of the many forms of swallowing impairment which in turn interfere both with the quality of life and survival itself.
Research using animal models has contributed significantly to realizing this goal and has the potential to contribute to future advances. The clinicians and researchers who work with animals understand this. But why should other researchers and the clinicians who see patients day in and day out care about this work? Surely we can all read about the results after they have been translated to human subjects? Results from studies of animal models have the potential to change and grow how we think about dysphagia research and practice in general, well beyond applying specific results to human studies.
At a recent meeting (Swallowing Think Tank, Dec. 2-3, 2016, Swallowing Systems Core at University of Florida, Humbert & Plowman, organizers, pers. com.), a number of researchers asked and discussed some fundamental questions, including What is a swallow? and What is normal? Through discussions of the existence of distinct dysphagia phenotypes, and of how to define, study, and measure them across the bench-to-bedside continuum, aspects of a conceptual framework emerged, provided in Fig. 1 .
The interaction of the first two boxes, the risk factors with the underlying physiology or pathophysiology, are the root causes producing the failure. These interactions can be important to the diagnosis and treatment plan, represented here by the clinical decision box. One significant contribution of animal research to the outcome box is to dissect out and provide detail on those first boxes, in particular the underlying physiology that is the causal mechanism of both accurate and acceptable performance, as well as performance failure (Fig. 2) . Swallowing is a motor function that requires the combined accurate movement or kinematics of a number of separate anatomical structures. Kinematics, in turn, are generated by muscle activity, which itself is generated by signals from the central nervous system (CNS) sent through peripheral nerves to the relevant muscles.
However, this is not simply a unidirectional pathway. Performance generates sensory signals that return to the CNS and can modify the next set of outgoing signals. This loop, represented in Fig. 3 , is the causal mechanism of each of the events that constitutes a swallow. Performance does not necessarily equate with a complete swallow, but with a subset of the activities within a swallow.
Animal models are uniquely able to facilitate understanding and testing of the causal mechanisms that produce good or bad performance in a normal, intact, and healthy individual. For failures in good performance, animal models can determine where in the loop, represented in Fig. 3 , that failure occurred. At each stage of the loop in Fig. 3 , animal models can provide more detailed data, in greater sample sizes with fewer ethical concerns than can a human sample. Although treatment is possible without understanding the complete mechanism of failure, understanding the full pathophysiology will accelerate the development of effective treatments by facilitating hypothesis-driven, physiology-based treatment testing in a scientifically rigorous manner.
Animal Research and the Generation of Performance
Numerous studies exist for each step of the loop in Fig. 3 . Excellent kinematic studies of human function exist, but a number of limitations on those studies do not exist in animal work. The amount of permissible radiation exposure is strictly limited in humans but not in animals. Frail and ill patients often cannot sustain a videofluoroscopic swallowing study (VFSS), whereas it is possible in most animal models of disease and frailty. Higher imaging speeds, 100-500 frames per second, are possible in animals, as compared to the 30 or 60 fps in human studies. Animal studies can have surgically implanted radio-opaque markers that permit detailed kinematic analyses of tongue movements not possible on humans [5, 14, 31] .
Muscle function is responsible for the kinematics or movements that are the basis of swallowing function. Yet, accurate recording and measurement of the electrical activity of muscles in humans is difficult. While surface electrodes are not invasive, they provide only a broad measurement of the underlying muscle signals. They cannot differentiate between the activities in large categories of muscles, such as the individual members of the infra-or suprahyoid groups that are critical for swallowing. Measurements of tongue muscle activity are nearly impossible without indwelling fine-wire bipolar electrodes. Such electrodes have been used to examine oral and pharyngeal function in humans although rarely and then in only in a few anatomically accessible muscles [4, 6, 20, 21] . In animals, surgical placement of electrodes in even deeply sited muscles is possible. The quality and quantity of data from such studies facilitates the determination of the relationship between the moving structure and the muscle generating that movement [24, 26, 27, 41, [48] [49] [50] . Information on neural control, both in terms of direct measurement of neural function and indirectly through lesion studies, has become more possible in human subjects through recent innovative techniques such as TMS [33] [34] [35] 39] . However, understanding specific aspects of neural control is still the realm of implanted electrodes, neural stimulation, and lesions; none of which are possible in human subjects. Stimulation studies can provide information on how specific nerves or CNS regions control or inhibit swallowing [13, 43, 46, 47] . Lesion studies can both mimic human injury and specify the extent of functional involvement of different regions of the brain [17, 45] . Finally, direct recordings from the CNS through chronically implanted electrodes can provide basic information on the spatial/temporal activity of those regions and so clarify the background to a number of human neural insults [1] [2] [3] 25] .
Ceteris Paribus and Understanding Pathophysiology
The hallmark of reproducible, evidence-based research is the concept of ceteris paribus, literally other things equal [30] . In studies of normal individuals, we can control many of the factors in the first two boxes in Fig. 3 , including age, gender, and other demographic variables. In studies of clinically compromised individuals, demographic factors become more difficult to control, and further complications, such as comorbidities and treatment compliance, are introduced. We can limit studies to a statistical sample of a particular disease entity, such as Parkinson's disease, or a condition, such as preterm birth, or an injury, such as traumatic brain injury. However, these diagnoses are themselves complex categories, with a variable extent of pathology and etiology. For some of these, it is not clear where in the loop (Fig. 3 ) the problem arises. Identifying the causal pathway deficit that produces failures in swallowing and deglutition in the complex, hierarchical, interacting physiological dysfunctions that result from disease etiologies is often not straightforward. Human clinical subjects represent the same wonderful variation, the same marvelously complicated packages that characterize all human endeavors. Although it is possible to collect data for each step in Fig. 3 from human subjects, because of ethical limitations, the data are not as complete, nor the datasets as large, as they can be from animal subjects.
Animals offer the opportunity for clean and uncomplicated studies of the impact of insult and the effect of intervention at different stages in presumptive etiological pathways. Ceteris paribus is inherent in the design of the study. The SOD1-G93A transgenic rodents are validated models of oral-stage dysphagia for bulbar deficits of Amyotrophic Lateral Sclerosis [28, 32] . There are multiple models of Parkinson's disease, including (6-OHDA)-induced DA depletion [8, 37] , surgical lesions [42] , and PINK KO genetic models [22, 23] . Surgical or pharmacological models of stroke in rodents have been common, but are now being developed and validated for examining dysphagia [19, 44] . Injuries that are associated with dysphagia, such as damage to branches of the vagus nerve, recurrent or superior laryngeal nerve [11, 12, 16, 38] , or other sensory deficits [18] , can be relatively easily duplicated in animal models.
In general, a number of concerns in human studies are much reduced. If the impact of an insult is subtle, and effect size is small, or swamped by inter-individual variation, having a large sample may be important to see the effect. Large sample sizes, either in number of individuals, or number of swallows, are relatively easy to obtain in animal models. Another issue is that swallowing problems are often considered doubly hidden. Firstly, unlike other sensorimotor tasks such as locomotion or reaching, some form of imaging is necessary to view the swallow. The gold standard for such imaging is the VFSS, which has radiation risks [36] . Secondly, silent aspiration, where the patient is unaware of the problem is a significant issue [10, 40, 52] . Uncovering these hidden problems is significantly easier with an animal model and a large sample size.
For age-based studies, either of the very old [29, 42] or the very young [7, 9, 15] , animal models answer both ethical and logistic challenges. The old and the young tend to be frailer than young or mid-aged adults. Furthermore, the separation of the effects of age, either young or old, from other clinical issues is difficult in human beings [51] . From the purely practical point of view, aging or normal development in humans represents changes that can occur over years. Some animal models represent a compressed timeline that makes longitudinal work possible. For developmental studies, the changes in airway protection necessitated by weaning are difficult to study on a human ontogenetic time scale.
Animal Models and Human Dysphagia
Animal models can provide unique data and insight into both normal and abnormal swallowing that is not possible in human subjects. This ability is due in part to ethical limitations in human research. Alternatively, because of the ability to control the sample, design, and methodology in animal studies, different aspects may be clarified. Removing comorbidities and human compliance concerns enhances the reliability of the results. Yet, in the end, much of the value of animal research lies in what it tells us about human dysphagia. The results in the studies cited here, and the ongoing research programs that generated these results, are worth understanding. They can generate the specific hypotheses that can be tested in human subjects. They can validate non-invasive methodologies or map results from invasive methodologies onto non-invasive methodologies that can be used with frail patients.
The justification for animal research depends on workers in human clinical research and the clinicians who apply that research understanding and appreciating how the translation from bench to beside is made. In this regard, animal research provides two key contributions to our understanding of dysphagia. The first is a more complete characterization of the physiology of both normal and pathological swallow than is possible in human subjects. The second is suggesting of specific, physiological, targets for the development and testing of treatment interventions to improve dysphagia outcomes.
